Risk Factors of Cardiovascular Death after Venous Thromboembolism: Results from a Prospective Cohort Study
Steve Raoul Noumegni1,2, Vincent Mansourati1,3, Cécile Tromeur1,2
1Department of Internal Medicine, Vascular Medicine and Pneumology, Brest Teaching Hospital, Brest, France.
Insights
Patients with venous thromboembolism (VTE) face higher cardiovascular death risks. Key factors include age, cancer, unprovoked VTE, tobacco use, hypertension, heart failure, respiratory failure, and atrial fibrillation.
Area of Science:
- Cardiology
- Vascular Medicine
- Epidemiology
Background:
- Cardiovascular deaths (CVDTs) are more prevalent in patients with venous thromboembolism (VTE) compared to the general population.
- Specific risk factors for CVDTs in VTE patients remain underexplored.
Purpose of the Study:
- To identify and describe the risk factors associated with cardiovascular deaths (CVDTs) in patients diagnosed with venous thromboembolism (VTE).
Main Methods:
- A multicenter prospective cohort study was conducted.
- Fine and Gray subdistribution hazard models were employed to analyze the data.
- The study included 3,988 patients with a median follow-up of 5 years.
Main Results:
- Over 5 years, 10.7% of patients experienced CVDTs.
- Significant risk factors identified include advanced age, cancer-associated VTE, unprovoked VTE, past and current tobacco use, hypertension, chronic heart failure, chronic respiratory failure, and atrial fibrillation.
- Direct oral anticoagulants and treatment duration exceeding 3 months were associated with reduced CVDT risk.
Conclusions:
- Cardiovascular death risk in VTE patients is influenced by traditional cardiovascular risk factors.
- VTE characteristics and patient comorbidities are also significant contributors to CVDT risk.
- Understanding these factors can inform preventative strategies and improve outcomes for VTE patients.
Background:
Cardiovascular deaths (CVDTs) are more frequent in patients with venous thromboembolism (VTE) than in the general population; however, risk factors associated with this increased risk of CVDT in patients with VTE are not described.
Methods:
To determine the risk factors of CVDT in patients with VTE from a multicenter prospective cohort study, Fine and Gray subdistribution hazard models were conducted.
Results:
Of the 3,988 included patients, 426 (10.7%) died of CVDT during a median follow-up of 5 years. The risk factors of CVDT after multivariate analyses were: age of 50 to 65 years (vs. <50 years, hazard ratio [HR]: 3.22, 95% confidence interval [CI]: 1.67-6.62), age >65 years (vs. <50 years, HR: 7.60, 95% CI: 3.73-15.52), cancer-associated VTE (vs. transient risk factor-related VTE, HR: 1.73, 95% CI: 1.15-2.61), unprovoked VTE (vs. transient risk factor-related VTE, HR: 1.42, 95% CI: 1.02-2.00), past tobacco use (vs. never, HR: 1.43, 95% CI: 1.06-1.94), current tobacco use (vs. never, HR: 1.87, 95% CI: 1.15-3.01), hypertension (HR: 2.11, 95% CI: 1.51-2.96), chronic heart failure (HR: 2.28, 95% CI: 1.37-3.79), chronic respiratory failure (HR: 1.72, 95% CI: 1.02-2.89), and atrial fibrillation (HR: 1.67, 95% CI: 1.06-2.60). The risk of CVDT was significantly reduced with direct oral anticoagulants (vs. vitamin-K antagonists) and with longer duration of treatment (>3 months).
Conclusion:
Risk factors of CVDT after VTE include some traditional cardiovascular risk factors and other risk factors that are related to characteristics of VTE, and patients' comorbidities.
Related Concept Videos
Venous Thrombosis I: Introduction
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Venous Return
What is Venous Return?
Venous return refers to the rate at which blood flows back to the heart from the body's peripheral veins. It's an integral part of the circulatory system...
Venous Thrombosis IV: Nursing Management
Varicose Veins I: Introduction


